A Systematic Review and Meta-Analysis of Surgery for Retroperitoneal Sarcoma With Vascular Resection.
meta-analysis
outcomes
sarcoma
surgery
vascular
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
accepted:
15
08
2023
medline:
18
9
2023
pubmed:
18
9
2023
entrez:
18
9
2023
Statut:
epublish
Résumé
This meta-analysis examines the outcomes of patients undergoing surgery with vascular resection for retroperitoneal sarcoma. A systematic literature search based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was conducted, identifying five comparative retrospective cohort studies published from 2015 to 2021, with a total of 1,417 patients (180 in the vascular resection (VR) group and 1,237 in the control (no VR) group). The meta-analysis found that 30-day morbidity rates, as classified by Clavien-Dindo classification > 3, were higher in the VR group compared to the no VR group (46% versus 25%, odds ratio (OR): 1.84, 95% confidence interval (CI): 0.39-8.69, p=0.44). Local recurrence rates during the follow-up period were similar between the two groups (30% versus 30%, OR: 1.46, 95% CI: 0.50-4.25, p=0.49). However, distant recurrence was more frequent in the VR group (32% versus 8.5%, OR: 2.54, 95% CI: 1.05-6.13, p=0.04). In conclusion, although oncovascular procedures are feasible for patients with retroperitoneal sarcomas, the long-term outcomes appear to be worse when compared to procedures that do not involve vessel resections.
Identifiants
pubmed: 37719606
doi: 10.7759/cureus.43544
pmc: PMC10502323
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e43544Informations de copyright
Copyright © 2023, Rebelo et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Surg Oncol. 2018 Jul;118(1):127-137
pubmed: 29878363
Ann Surg. 2016 Mar;263(3):593-600
pubmed: 25915910
Open Med. 2009;3(3):e123-30
pubmed: 21603045
Eur J Surg Oncol. 2011 Dec;37(12):1017-24
pubmed: 21917411
J Surg Oncol. 2018 Jan;117(1):42-47
pubmed: 29194630
J Vasc Surg. 2016 Oct;64(4):1033-41
pubmed: 27374069
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Clin Case Rep. 2021 Aug 30;9(9):e04717
pubmed: 34484756
J Surg Oncol. 2017 Sep;116(3):313-319
pubmed: 28557016
Eur J Surg Oncol. 2021 Dec;47(12):3004-3010
pubmed: 34364722
Eur J Surg Oncol. 2017 Feb;43(2):407-415
pubmed: 27914772
J Surg Oncol. 2018 Jan;117(1):33-41
pubmed: 29315649
Ann Surg Oncol. 2012 Sep;19(9):2981-91
pubmed: 22476756
PLoS One. 2011;6(8):e20294
pubmed: 21826194
Med Glas (Zenica). 2022 Aug 01;19(2):
pubmed: 35716083
BMC Med Res Methodol. 2005 Apr 20;5:13
pubmed: 15840177
Surgery. 2021 Sep;170(3):848-856
pubmed: 33812753
Ann Surg. 2016 Jun;263(6):1199-206
pubmed: 26135697